Saltire Remedies Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.70 M
- Revenue Growth -52.91%
- Profit Growth -72.39%
- Ebitda -321.23%
- Net Worth 12.68%
- Total Assets -21.82%
About Saltire Remedies
Saltire Remedies Private Limited (SRPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 December 2016 (Eight years and one month 8 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.70 M.
Prasad Sriram, Sriram Kiran, and Latha Sriram serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2016PTC113710
-
Company No.
113710
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Dec 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Saltire Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasad Sriram
|
Director | 27-Dec-2016 | Current |
|
Sriram Kiran
|
Director | 03-Apr-2023 | Current |
|
Latha Sriram
|
Director | 01-Feb-2021 | Current |
Financial Performance of Saltire Remedies.
Saltire Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 52.91% decrease. The company also saw a substantial fall in profitability, with a 72.39% decrease in profit. The company's net worth Soared by an impressive increase of 12.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saltire Remedies?
In 2021, Saltire Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.70 M
₹0
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2019 | The South Indian Bank Limited | ₹0.70 M | Open |
How Many Employees Work at Saltire Remedies?
Unlock and access historical data on people associated with Saltire Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saltire Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saltire Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
